Lilly profit beats forecast
April 24 (Reuters) - Eli Lilly and Co on Wednesday reported higher-than-expected first-quarter earnings, helped by sales of its treatments for diabetes, depression and lung cancer.
The company said it had net income of $1.55 billion, or $1.42 per share. That compared with $1.01 billion, or 91 cents per share, in the year-earlier period.
- Divided, Scots prepare to vote on fate of the United Kingdom |
- IPhone emerges from 'bygone era', reviewers hail bigger handset
- Fed renews zero rate pledge, but hints at steeper rate hike path |
- Apple to unveil new iPads, operating system on Oct. 21: report
- Boeing, SpaceX win contracts to build 'space taxis' for NASA